Jenburkt Pharmaceuticals Announces 41st AGM on Sep 4, 2026
Jenburkt Pharmaceuticals Ltd has announced its 41st Annual General Meeting (AGM) will be held on Friday, September 4, 2026, at 3:30 p.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has also shared its Annual Report for the financial year 2025-26, which includes the AGM notice, audited financial statements, cash flow statements, Directors' report, management discussion and analysis, auditors' report with an unmodified opinion, and a report on Corporate Governance. The Annual Report is being distributed electronically as per regulatory guidelines, with a web-link provided for members who have not registered their email addresses. The report highlights the company's long-standing commitment to CSR, rooted in its founding family's values.
Key Highlights
- 41st Annual General Meeting scheduled for September 4, 2026.
- Meeting to be held virtually via VC/OAVM.
- Annual Report 2025-26 includes financials and governance reports.
- Electronic distribution of Annual Report and AGM notice.
- Company emphasizes long-standing CSR philosophy.
Price Impact
More from JENBURPH